Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
| Review By | Apply | May Apply | Neutral | Avoid | Not Rated |
|---|---|---|---|---|---|
| Count | 0 | 0 | 0 | 0 | 0 |
| % | 0 | 0 | 0 | 0 | 0 |
The Captial Market (CapitalMarket.com) rating for Metropolis Healthcare IPO is 43. Their analysis recommends Avoid, However active risk seekers can try for the IPO.
| Reviewer | Rating Score | Rating |
|---|---|---|
| Capital Market | 43 | Avoid, However active risk seekers can try |
[Dilip Davda] Although the sector is fragmented and highly unorganized, MHL has created a niche place amongst organized players with many firsts to its credit. Though the issue appears fully priced, asset light and debt-free status make this offer lucrative. Investors may consider an investment for the long term. Read detail review...
Metropolis Healthcare IPO Reviews, analysis and views by popular members. Read Metropolis Healthcare Ltd. IPO reviews by retail investors to find recommended ipo to buy.
| Review By | Apply | May Apply | Neutral | Avoid |
|---|---|---|---|---|
| Count | 0 | 0 | 0 | 0 |
| % | 0.00 | 0.00 | 0.00 | 0.00 |
| Member | Review |
|---|---|
| No recommendation found. Be the first to post the recommendation. | |
Note:
Useful Articles
RHP